The Supreme Court today upheld one province’s bid to regulate the cost of generic drugs. The ruling is expected to set a regulatory pattern nationwide, a legal analyst told Blacklock’s. Justices in a unanimous 7-0 judgment concluded Ontario was within its rights in attempting to enforce a price cap by banning rebates paid to pharmacies by drug manufacturers.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
